Pathophysiology of respiratory failure in patients with osteogenesis imperfecta: a systematic review.
Osteogenesis Imperfecta
lung pathophysiology
pulmonary function
respiratory mechanics
thoracic skeletal changes
Journal
Annals of medicine
ISSN: 1365-2060
Titre abrégé: Ann Med
Pays: England
ID NLM: 8906388
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
27
9
2021
pubmed:
28
9
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
Respiratory failure is a major cause of death in patients with Osteogenesis Imperfecta. Moreover, respiratory symptoms seem to have a dramatic impact on their quality of life. It has long been thought that lung function disorders in OI are mainly due to changes in the thoracic wall, caused by bone deformities. However, recent studies indicate that alterations in the lung itself can also undermine respiratory health. Is there any intrapulmonary alteration in Osteogenesis Imperfecta that can explain decreased pulmonary function? The aim of this systematic literature review is to investigate to what extent intrapulmonary or extrapulmonary thoracic changes contribute to respiratory dysfunction in Osteogenesis Imperfecta. A literature search (in PubMed, Embase, Web of Science, and Cochrane), which included articles from inception to December 2020, was performed in accordance with the PRISMA guidelines. Pulmonary function disorders have been described in many studies as secondary to scoliosis or to thoracic skeletal deformities. The findings of this systematic review suggest that reduced pulmonary function can also be caused by a primary pulmonary problem due to intrinsic collagen alterations. Based on the most recent studies, the review indicates that pulmonary defects may be a consequence of abnormal collagen type I distorting the intrapulmonary structure of the lung. Lung function deteriorates further when intrapulmonary defects are combined with severe thoracic abnormalities. This systematic review reveals novel findings of the underlying pathological mechanism which have clinical and diagnostic implications for the assessment and treatment of pulmonary function disorders in Osteogenesis Imperfecta.KEY MESSAGESDecreased pulmonary function in Osteogenesis Imperfecta can be attributed to primary pulmonary defects due to intrapulmonary collagen alterations and not solely to secondary problems arising from thoracic skeletal dysplasia.Type I collagen defects play a crucial role in the development of the lung parenchyma and defects, therefore, affect pulmonary function. More awareness is needed among physicians about pulmonary complications in Osteogenesis Imperfecta to develop novel concepts on clinical and diagnostic assessment of pulmonary functional disorders.
Identifiants
pubmed: 34569391
doi: 10.1080/07853890.2021.1980819
pmc: PMC8477932
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1676-1687Références
Front Endocrinol (Lausanne). 2020 Aug 11;11:481
pubmed: 32849274
J Clin Pathol. 1996 Aug;49(8):627-30
pubmed: 8881910
Spine (Phila Pa 1976). 2019 Aug 1;44(15):1057-1063
pubmed: 31335789
Arch Osteoporos. 2020 Oct 2;15(1):153
pubmed: 33009598
Spine (Phila Pa 1976). 1999 Aug 15;24(16):1673-8
pubmed: 10472101
Clin Orthop Relat Res. 2020 Dec;478(12):2833-2843
pubmed: 32649370
Hum Pathol. 1980 Jul;11(4):353-66
pubmed: 6997183
J Adv Res. 2019 Oct 22;21:177-185
pubmed: 32071786
Paediatr Respir Rev. 2006 Jun;7(2):152-60
pubmed: 16765303
Clin Orthop Relat Res. 1992 Sep;(282):250-72
pubmed: 1516320
Implant Dent. 2002;11(3):280-5
pubmed: 12271567
Spine (Phila Pa 1976). 2013 Jan 15;38(2):E94-100
pubmed: 23138403
Hum Mol Genet. 2012 Aug 15;21(16):3535-45
pubmed: 22589248
Ther Clin Risk Manag. 2010 Sep 07;6:367-81
pubmed: 20856683
Bone. 1989;10(3):165-71
pubmed: 2803853
J Pediatr. 2004 Dec;145(6):813-8
pubmed: 15580207
Clin Respir J. 2014 Oct;8(4):437-43
pubmed: 24308436
Pediatr Pulmonol. 1995 Nov;20(5):301-6
pubmed: 8903902
J Med Genet. 1979 Apr;16(2):101-16
pubmed: 458828
Am J Respir Crit Care Med. 2016 Feb 15;193(4):460-1
pubmed: 26431159
J Spinal Disord Tech. 2006 Jul;19(5):368-72
pubmed: 16826011
Am J Med Genet A. 2014 Jun;164A(6):1470-81
pubmed: 24715559
Clin Genet. 2018 Dec;94(6):502-511
pubmed: 30152014
J Clin Invest. 1960 Jan;39:8-14
pubmed: 14432825
Am Rev Respir Dis. 1959 Jul;80(1, Part 2):45-9
pubmed: 13670403
PLoS One. 2010 May 11;5(5):e10560
pubmed: 20485499
PLoS One. 2012;7(4):e35965
pubmed: 22558284
Pan Afr Med J. 2015 May 05;21:11
pubmed: 26401205
Thorax. 1986 Jun;41(6):418-28
pubmed: 3024347
Am J Physiol Lung Cell Mol Physiol. 2020 Apr 1;318(4):L592-L605
pubmed: 32022592
Am Rev Respir Dis. 1973 Nov;108(5):1258-60
pubmed: 4746589
Am Rev Respir Dis. 1979 Oct;120(4):799-811
pubmed: 315738
Proc Soc Exp Biol Med. 1995 Jun;209(2):118-40
pubmed: 7770462
J Biol Chem. 1974 May 10;249(9):2674-83
pubmed: 4364025
J Matern Fetal Neonatal Med. 2016;29(11):1725-30
pubmed: 26135769
J Med Assoc Thai. 2012 Jan;95 Suppl 1:S190-4
pubmed: 23964465
Pediatr Pulmonol. 2018 Jul;53(7):964-972
pubmed: 29766672
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
Mol Syndromol. 2011 Dec;2(1):1-20
pubmed: 22570641
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481
J Bone Miner Res. 2016 Dec;31(12):2159-2166
pubmed: 27345018
Dan Med J. 2018 Apr;65(4):
pubmed: 29619932
Pediatr Res. 2018 Jun;83(6):1165-1171
pubmed: 29538357
Nat Rev Dis Primers. 2017 Aug 18;3:17052
pubmed: 28820180